Timpani Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Timpani Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-129,306	Closed	-$619K	–	119
2015 Q4	$619K	Sell	129,306 -34,428	-21%	-$195K	0.25%	90
2015 Q3	$910K	Buy	163,734 +77,495	+90%	+$572K	0.37%	86
2015 Q2	$686K	Sell	86,239 -279,734	-76%	-$2.4M	0.2%	87
2015 Q1	$3.84M	Sell	365,973 -11,734	-3%	-$160K	1.15%	44
2014 Q4	$4.54M	Sell	377,707 -181,798	-32%	-$2.76M	1.78%	14
2014 Q3	$9.56M	Buy	559,505 +37,858	+7%	+$549K	4.37%	1
2014 Q2	$6.3M	Buy	521,647 +85,224	+20%	+$808K	2.83%	4
2014 Q1	$3.68M	Buy	436,423 +197,969	+83%	+$1.6M	1.95%	16
2013 Q4	$1.4M	Buy	+238,454	New	+$1.23M	0.7%	57

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Timpani Capital Management's BDSI Position: Q1 2016 in Review

Timpani Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2016, closing a stake of 129,306 shares — an estimated $619K sold.

Timpani Capital Management first reported a position in BDSI in Q4 2013 and held it in 9 quarters. The position peaked at $9.56M in Q3 2014. 105 funds tracked by Wall St. Rank hold BDSI as of Q1 2016.

Timpani Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2016 after selling out during the quarter.
Timpani Capital Management sold 129,306 BioDelivery Sciences International, Inc. shares in Q1 2016, an estimated $619K.
Timpani Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 9 quarters.
Timpani Capital Management's BioDelivery Sciences International, Inc. position peaked at $9.56M in Q3 2014.
105 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2016.

Based on Timpani Capital Management's 13F filing for Q1 2016, filed 13 May 2016.